Histological and in vitro studies supporting decreased uteroplacental blood flow as explanation for digital defects after administration of vasodilators.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Teratology

• Publication date

  1990-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/TERA.1420410210PMID 2321163
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo pharmacokinetics of felodipine predicted from in vitro studies in rat, dog and man.

  2009cited by this paper
• Dual staining of some sulfated mucopolysaccharides with alcian blue (pH 1.0) and ruthenium red (pH 2.5)

  2004cited by this paper
• Treatment of essential hypertension with felodipine in combination with a diuretic

  2004cited by this paper
• Digital defects induced by vasodilating agents: relationship to reduction in uteroplacental blood flow.

  1989cited by this paper
• Hyperphalangeal bones induced in rat pups by maternal treatment with nifedipine.

  1988cited by this paper
• Effects of molecular oxygen on chick limb bud chondrogenesis.

  1988cited by this paper
• Cardiovascular and Uterine Blood Flow Changes During Nicardipine HC1 Tocolysis in the Rabbit

  1987cited by this paper
• Uterine trauma and limb defects.

  1987cited by this paper
• Pharmacokinetics and haemodynamic effects of felodipine as monotherapy in hypertensive patients.

  1987cited by this paper
• Some observations on the effects of a calcium channel blocker, nitrendipine, in early human pregnancy.

  1987cited by this paper
• Effects of Verapamil on Uterine Blood Flow and Maternal Cardiovascular Function in the Awake Pregnant Ewe

  1985cited by this paper
• Determination of felodipine in plasma by capillary gas chromatography with electron capture detection.

  1984cited by this paper
• Treatment of severe pregnancy‐associated hypertension with the calcium antagonist nifedipine

  1984cited by this paper
• Lack of effect of indomethacin on mesenchymal limb-bud cells in vitro.

  1984cited by this paper
• Development of chick limb bud chondrocytes in cell culture: morphologic and oxidative metabolic observations.

  1981cited by this paper
• Detection of teratogenic compounds using differentiating embryonic cells in culture

  1980cited by this paper
• Evaluation of a program of bed rest in the treatment of chronic hypertension in pregnancy.

  1979cited by this paper
• Evaluation of a Program of Bed Rest in the Treatment of Chronic Hypertension in Pregnancy

  1979cited by this paper
• The effect of changes in perfusion pressure on uteroplacental blood flow in the pregnant rabbit.

  1976cited by this paper
• Fetal pathology in rats following uterine-vessel clamping on day 14 of gestation.

  1974cited by this paper
• The control of muscle and cartilage development in the chick limb: the role of differential vascularization.

  1973cited by this paper
• Effects of hydralazine on uteroplacental and fetal circulations.

  1970cited by this paper
• The effect of uterine vascular clamping on the development of rat embryos three to fourteen days old

  1964cited by this paper
• Uterine Vascular Clamping: New Procedure for the Study of Congenital Malformations

  1960cited by this paper

• Considerations for the development of guidance on dose level selection for developmental and reproductive toxicity studies.

  2024cites this paper
• Teratogenicity and Reactive Oxygen Species after transient embryonic hypoxia: Experimental and clinical evidence with focus on drugs causing failed abortion in humans.

  2023cites this paper
• Syndromic disorders caused by gain-of-function variants in KCNH1, KCNK4, and KCNN3—a subgroup of K+ channelopathies

  2021cites this paper
• Gain-of-Function Mutations in KCNN3 Encoding the Small-Conductance Ca2+-Activated K+ Channel SK3 Cause Zimmermann-Laband Syndrome.

  2019cites this paper
• L-type voltage-gated Ca2+ channel CaV1.2 regulates chondrogenesis during limb development

  2019cites this paper
• Chronic hypertension in pregnancy : evaluating mechanism and treatment in an ethnically diverse group to assess factors contributing to maternal and perinatal outcome

  2017cites this paper
• Voltage-Dependent Calcium Channels in Chondrocytes: Roles in Health and Disease

  2015cites this paper
• Maternal toxicity.

  2013cites this paper
• Assessment of Drug-Induced Cardiotoxicity during Rat Embryo Development

  2013cites this paper
• ILSI/HESI maternal toxicity workshop summary: maternal toxicity and its impact on study design and data interpretation.

  2011cites this paper
• The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study.

  2008cites this paper
• In utero exposure to mycophenolate mofetil: A characteristic phenotype?

  2008cites this paper
• Embryonic cardiac arrhythmia and generation of reactive oxygen species: common teratogenic mechanism for IKr blocking drugs.

  2007cites this paper
• Maternally Mediated Effects on Development

  2005cites this paper
• Pathogenesis of Abnormal Development

  2005cites this paper
• Teratological consequences of nitric oxide synthesis inhibition.

  2004cites this paper
• The Nitric Oxide Synthesis Inhibitor Nω-Nitro-L-Arginine Methyl Ester (L-NAME) Causes Limb Defects in Mouse Fetuses: Protective Effect of Acute Hyperoxia

  2003cites this paper
• Further evidence for the role of free radicals in the limb teratogenicity of L-NAME.

  2002cites this paper
• Class III antiarrhythmics and phenytoin: teratogenicity due to embryonic cardiac dysrhythmia and reoxygenation damage.

  2001cites this paper
• Effects of Antihypertensive Drugs on the Unborn Child

  2000cites this paper
• Vasoactive teratogens and digital blood flow.

  1999cites this paper
• Role of free radicals in the limb teratogenicity of L-NAME (N(G)-nitro-(L)-arginine methyl ester): a new mechanistic model of vascular disruption.

  1999cites this paper
• Limb reduction defects in the A/J mouse strain associated with maternal blood loss.

  1998cites this paper
• Pharmacologically induced embryonic dysrhythmia and episodes of hypoxia followed by reoxygenation: a common teratogenic mechanism for antiepileptic drugs?

  1998cites this paper
• Cardiovascular alterations in rat fetuses exposed to calcium channel blockers.

  1997cites this paper
• Calcium-channel blockers in the management of preterm labour.

  1997cites this paper
• Cardiovascular Active Drugs

  1997cites this paper
• Hypoxia and Altered Redox Status in Embryotoxicity

  1997cites this paper
• Hypertension in pregnancy: use of antihypertensive drugs

  1997cites this paper
• Initiation of phenytoin teratogenesis: pharmacologically induced embryonic bradycardia and arrhythmia resulting in hypoxia and possible free radical damage at reoxygenation.

  1997cites this paper
• Congenital Limb Reduction Defects in Infants: A Look at Possible Associations with Maternal Smoking and Hypertension

  1997cites this paper
• Prenatal toxicity studies in rats and rabbits with the calcium channel blocker diproteverine.

  1996cites this paper
• The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study.

  1996cites this paper
• Suppressive effects of Bay K 8644 on toxicity of calcium channel blockers in cultured rat embryos.

  1996cites this paper
• Reactive oxygen species in developmental toxicity: review and hypothesis.

  1996cites this paper
• CVS-exposed limb deficiency defects with or without other birth defects: presentation of six cases born during a period of nine years.

  1996cites this paper
• Phenytoin causes phalangeal hypoplasia in the rabbit fetus at clinically relevant free plasma concentrations.

  1995cites this paper
• Studies on reproductive toxicity of iloprost in rats, rabbits and monkeys.

  1995cites this paper
• Chemical teratogenesis.

  1993cites this paper
• Reproductive toxicity studies of the antihypertensive agent felodipine in the rat.

  1993cites this paper
• A new technique for culturing rat embryos between gestation days 14 and 15.

  1993cites this paper
• Malformations and deformations in abdominal pregnancy.

  1993cites this paper
• Effects of hydralazine on pregnant rats and their fetuses.

  1993cites this paper
• Severe limb abnormalities: analysis of a cluster of five cases born during a period of 45 days.

  1993cites this paper
• Identical phalangeal defects induced by phenytoin and nifedipine suggest fetal hypoxia and vascular disruption behind phenytoin teratogenicity.

  1992cites this paper
• Ischemia/reperfusion: a new hypothesis for the developmental toxicity of cocaine.

  1992cites this paper
• Histopathological and hemodynamic studies supporting hypoxia and vascular disruption as explanation to phenytoin teratogenicity.

  1992cites this paper
• Role of maternal toxicity in assessing developmental toxicity in animals: a discussion.

  1992cites this paper
• Adverse drug reactions in the view of clinical pharmacology: a focus on the female population

  year unknowncites this paper
• Adverse drug reactions in the view of clinical pharmacology: a focus on the female population

  year unknowncites this paper